< 1 minute read
Dec. 16, 2021

VIP152 (BAY 1251152): a DK9 Inhibitor

VIP152 (BAY 1251152)

50x family-selective CDK9 kinase inhibitor IV agent (5-30 mg QW) in Ph. I for cancer scaffold hop from atuveciclib Journal of Medicinal Chemistry Bayer, Berlin, DE / Vincerx, Palo Alto, US

twitterlinkedinprintemail